Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Incyte Genomics (INCY)

$113.31 −$2.40 (−2.07%)

Day’s range
$112.75–$115.93
Volume
2.3M

INCY price history

INCY closed at $113.31 on Oct. 26, 2026. Over the past year, its daily close ranged from $90.18 on Oct. 29, 2025 to $129.93 on July 28, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $90 to $130, not from zero.
Data table: INCY daily closes, the past year
INCY daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$113.31
Oct. 23, 2026$115.71
Oct. 22, 2026$116.93
Oct. 21, 2026$113.44
Oct. 20, 2026$116.62
Oct. 19, 2026$113.25
Oct. 16, 2026$113.07
Oct. 15, 2026$113.27
Oct. 14, 2026$111.57
Oct. 13, 2026$108.62
Oct. 12, 2026$111.36
Oct. 9, 2026$112.79
Oct. 8, 2026$112.75
Oct. 7, 2026$113.44
Oct. 6, 2026$112.73
Oct. 5, 2026$114.13
Oct. 2, 2026$115.30
Oct. 1, 2026$117.14
Sept. 30, 2026$121.35
Sept. 29, 2026$123.20
Sept. 28, 2026$124.82
Sept. 25, 2026$123.89
Sept. 24, 2026$124.44
Sept. 23, 2026$124.64
Sept. 22, 2026$126.93
Sept. 21, 2026$124.65
Sept. 18, 2026$125.31
Sept. 17, 2026$127.62
Sept. 16, 2026$124.75
Sept. 15, 2026$121.74
Sept. 14, 2026$122.19
Sept. 11, 2026$121.47
Sept. 10, 2026$123.28
Sept. 9, 2026$126.01
Sept. 8, 2026$124.40
Sept. 4, 2026$126.75
Sept. 3, 2026$128.00
Sept. 2, 2026$128.83
Sept. 1, 2026$125.01
Aug. 31, 2026$123.22
Aug. 28, 2026$124.37
Aug. 27, 2026$127.74
Aug. 26, 2026$128.12
Aug. 25, 2026$129.72
Aug. 24, 2026$127.98
Aug. 21, 2026$127.81
Aug. 20, 2026$127.22
Aug. 19, 2026$128.47
Aug. 18, 2026$123.47
Aug. 17, 2026$123.50
Aug. 14, 2026$120.16
Aug. 13, 2026$120.52
Aug. 12, 2026$120.77
Aug. 11, 2026$121.07
Aug. 10, 2026$121.55
Aug. 7, 2026$120.56
Aug. 6, 2026$118.38
Aug. 5, 2026$119.80
Aug. 4, 2026$120.60
Aug. 3, 2026$118.43
July 31, 2026$119.52
July 30, 2026$122.99
July 29, 2026$127.10
July 28, 2026$129.93
July 27, 2026$118.87
July 24, 2026$117.67
July 23, 2026$116.69
July 22, 2026$115.79
July 21, 2026$117.39
July 20, 2026$115.65
July 17, 2026$117.25
July 16, 2026$116.65
July 15, 2026$115.09
July 14, 2026$114.88
July 13, 2026$114.23
July 10, 2026$116.71
July 9, 2026$118.52
July 8, 2026$117.26
July 7, 2026$118.05
July 6, 2026$115.62
July 2, 2026$116.86
July 1, 2026$113.81
June 30, 2026$113.36
June 29, 2026$114.66
June 26, 2026$113.75
June 25, 2026$107.53
June 24, 2026$108.46
June 23, 2026$104.40
June 22, 2026$103.66
June 18, 2026$98.22
June 17, 2026$98.99
June 16, 2026$99.75
June 15, 2026$101.98
June 12, 2026$108.53
June 11, 2026$107.83
June 10, 2026$105.39
June 9, 2026$103.23
June 8, 2026$100.64
June 5, 2026$102.38
June 4, 2026$101.24
June 3, 2026$97.98
June 2, 2026$92.24
June 1, 2026$95.59
May 29, 2026$96.74
May 28, 2026$97.50
May 27, 2026$97.34
May 26, 2026$97.10
May 22, 2026$97.16
May 21, 2026$97.41
May 20, 2026$97.08
May 19, 2026$95.60
May 18, 2026$95.19
May 15, 2026$95.31
May 14, 2026$97.63
May 13, 2026$98.82
May 12, 2026$99.13
May 11, 2026$100.32
May 8, 2026$98.56
May 7, 2026$97.77
May 6, 2026$99.85
May 5, 2026$97.47
May 4, 2026$97.14
May 1, 2026$96.91
April 30, 2026$95.27
April 29, 2026$99.10
April 28, 2026$97.74
April 27, 2026$95.72
April 24, 2026$94.65
April 23, 2026$95.47
April 22, 2026$96.74
April 21, 2026$96.22
April 20, 2026$96.92
April 17, 2026$97.82
April 16, 2026$95.32
April 15, 2026$97.10
April 14, 2026$97.69
April 13, 2026$95.55
April 10, 2026$96.07
April 9, 2026$96.96
April 8, 2026$95.89
April 7, 2026$93.69
April 6, 2026$94.86
April 2, 2026$95.93
April 1, 2026$94.30
March 31, 2026$94.12
March 30, 2026$90.33
March 27, 2026$90.30
March 26, 2026$92.26
March 25, 2026$92.23
March 24, 2026$90.62
March 23, 2026$90.45
March 20, 2026$90.78
March 19, 2026$92.95
March 18, 2026$92.24
March 17, 2026$94.22
March 16, 2026$93.00
March 13, 2026$92.54
March 12, 2026$92.03
March 11, 2026$94.66
March 10, 2026$96.02
March 9, 2026$97.10
March 6, 2026$95.94
March 5, 2026$97.33
March 4, 2026$98.86
March 3, 2026$98.07
March 2, 2026$100.04
Feb. 27, 2026$101.27
Feb. 26, 2026$100.09
Feb. 25, 2026$99.98
Feb. 24, 2026$101.05
Feb. 23, 2026$100.85
Feb. 20, 2026$101.32
Feb. 19, 2026$101.73
Feb. 18, 2026$102.99
Feb. 17, 2026$101.16
Feb. 13, 2026$101.10
Feb. 12, 2026$100.75
Feb. 11, 2026$98.84
Feb. 10, 2026$100.05
Feb. 9, 2026$109.03
Feb. 6, 2026$108.39
Feb. 5, 2026$102.76
Feb. 4, 2026$102.60
Feb. 3, 2026$100.92
Feb. 2, 2026$102.67
Jan. 30, 2026$100.07
Jan. 29, 2026$101.08
Jan. 28, 2026$101.18
Jan. 27, 2026$103.47
Jan. 26, 2026$102.58
Jan. 23, 2026$101.99
Jan. 22, 2026$105.06
Jan. 21, 2026$104.67
Jan. 20, 2026$102.62
Jan. 16, 2026$106.21
Jan. 15, 2026$105.24
Jan. 14, 2026$105.95
Jan. 13, 2026$103.43
Jan. 12, 2026$106.33
Jan. 9, 2026$106.87
Jan. 8, 2026$105.92
Jan. 7, 2026$110.57
Jan. 6, 2026$106.66
Jan. 5, 2026$101.79
Jan. 2, 2026$101.42
Dec. 31, 2025$98.77
Dec. 30, 2025$98.91
Dec. 29, 2025$99.29
Dec. 26, 2025$100.11
Dec. 24, 2025$100.44
Dec. 23, 2025$100.91
Dec. 22, 2025$100.71
Dec. 19, 2025$102.69
Dec. 18, 2025$97.31
Dec. 17, 2025$97.63
Dec. 16, 2025$97.03
Dec. 15, 2025$98.64
Dec. 12, 2025$95.41
Dec. 11, 2025$96.10
Dec. 10, 2025$95.17
Dec. 9, 2025$95.16
Dec. 8, 2025$96.70
Dec. 5, 2025$102.52
Dec. 4, 2025$100.46
Dec. 3, 2025$101.50
Dec. 2, 2025$101.44
Dec. 1, 2025$102.04
Nov. 28, 2025$104.46
Nov. 26, 2025$105.65
Nov. 25, 2025$105.55
Nov. 24, 2025$106.24
Nov. 21, 2025$102.06
Nov. 20, 2025$101.76
Nov. 19, 2025$101.32
Nov. 18, 2025$103.89
Nov. 17, 2025$104.17
Nov. 14, 2025$104.15
Nov. 13, 2025$105.41
Nov. 12, 2025$108.26
Nov. 11, 2025$108.16
Nov. 10, 2025$105.98
Nov. 7, 2025$105.98
Nov. 6, 2025$105.20
Nov. 5, 2025$105.70
Nov. 4, 2025$102.92
Nov. 3, 2025$101.57
Oct. 31, 2025$93.48
Oct. 30, 2025$92.59
Oct. 29, 2025$90.18
Oct. 28, 2025$91.65
Oct. 27, 2025$93.08

Key figures

52-week range
$90.18–$129.93Low Oct. 29, 2025; high July 28, 2026
Average daily volume
1.6MPast 3 months
Market value
$22.97B
Dividend yield
—
From 52-week high
−12.79%

Price change

1 month
−8.54%
3 months
−3.71%
Year to date
+14.72%
1 year
+24.13%

$1,000 a year ago

$1,000 put into INCY at the close on Oct. 24, 2025 would be worth $1,241.

Price only, dividends not included.

What Wall Street says about INCY

In the past 90 days, Wall Street firms published 20 rating or price-target actions on INCY: 1 new rating, 4 reiterated ratings and 15 raised price targets.

Rating and price-target actions on INCY, past 90 days
ActionRating
TD CowenRaises targetBuy$138 to $140
Truist SecuritiesRaises targetHold$105 to $115
HC Wainwright & Co.ReiteratesBuy$152
RBC CapitalRaises targetSector perform$109 to $114
StifelRaises targetBuy$145 to $157
Wells FargoRaises targetEqual-weight$116 to $128
HC Wainwright & Co.Raises targetBuy$150 to $152
JP MorganRaises targetNeutral$120 to $123
RBC CapitalReiteratesSector perform$109
Canaccord GenuityInitiates coverageBuy$152
HC Wainwright & Co.ReiteratesBuy$150
Piper SandlerRaises targetOverweight$110 to $130
MizuhoRaises targetOutperform$121 to $137
HC Wainwright & Co.ReiteratesBuy$150
Leerink PartnersRaises targetOutperform$131 to $155
BarclaysRaises targetOverweight$134 to $139
BMO CapitalRaises targetMarket perform$112 to $130
GuggenheimRaises targetBuy$136 to $150
HC Wainwright & Co.Raises targetBuy$140 to $150
RBC CapitalRaises targetSector perform$99 to $109

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Incyte Genomics Inc

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Headquarters
Wilmington, Del.
Employees
2,844
Listed
Nov. 3, 1993
Sector
Health care
Industry
Services-commercial physical & biological research

incyte.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about INCY is on the site yet.

  • IQVIQVIA Holdings Inc.
  • MEDPMedpace Holdings, Inc. Common Stock
  • CRLCharles River Laboratories International, Inc.
  • ABSIAbsci Corporation Common Stock
  • OABIOmniAb, Inc. Common Stock
  • NRCNRC Health Common Stock